This is the preview version of the Wisconsin State Legislature site.
Please see for the production version.
961.18(5m) (5m) Narcotic drugs not limited by quantity. Any material, compound, mixture, or preparation containing any of the following narcotic drugs, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.18(5m)(a) (a) Buprenorphine
961.18(6) (6) Exceptions. The controlled substances board may except by rule any compound, mixture or preparation containing any stimulant or depressant substance included in sub. (2m) or (3) from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.
961.18(7) (7) Anabolic steroids. Any material, compound, mixture, or preparation containing any quantity of any of the following anabolic steroids, including any of their esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers that are theoretically possible within the specific chemical designation:
961.18(7)(a) (a) Boldenone;
961.18(7)(am) (am) 19-Nor-4,9(10)-androstadienedione;
961.18(7)(az) (az) Boldione;
961.18(7)(b) (b) 4-chlorotestosterone, which is also called clostebol;
961.18(7)(c) (c) Dehydrochloromethyltestosterone;
961.18(7)(d) (d) 4-dihydrotestosterone, which is also called stanolone;
961.18(7)(e) (e) Drostanolone;
961.18(7)(em) (em) Desoxymethyltestosterone;
961.18(7)(f) (f) Ethylestrenol;
961.18(7)(g) (g) Fluoxymesterone;
961.18(7)(h) (h) Formebulone, which is also called fromebolone;
961.18(7)(i) (i) Mesterolone;
961.18(7)(j) (j) Methandienone, which is also called methandrostenolone;
961.18(7)(k) (k) Methandriol;
961.18(7)(L) (L) Methenolone;
961.18(7)(m) (m) Methyltestosterone;
961.18(7)(n) (n) Mibolerone;
961.18(7)(o) (o) Nandrolone;
961.18(7)(p) (p) Norethandrolone;
961.18(7)(q) (q) Oxandrolone;
961.18(7)(r) (r) Oxymesterone;
961.18(7)(s) (s) Oxymetholone;
961.18(7)(t) (t) Stanozolol;
961.18(7)(u) (u) Testolactone;
961.18(7)(v) (v) Testosterone;
961.18(7)(w) (w) Trenbolone.
961.18 History History: 1971 c. 219; 1981 c. 6; 1981 c. 206 ss. 32 to 40, 57; 1995 a. 448 ss. 181 to 200, 475, 476; Stats. 1995 s. 961.18; 1997 a. 220; 2009 a. 180; 2013 a. 351; ss. CSB 2.19, 2.21, 2.25, 2.29, 2.30, 2.37, 2.87, 2.89, Wis. adm. code.
961.18 Note NOTE: See 1993-94 Statutes for notes on actions by controlled substances board under s. 161.11 (1), 1993 Stats.
961.19 961.19 Schedule IV tests.
961.19(1m)(1m)The controlled substances board shall add a substance to schedule IV upon finding that:
961.19(1m)(a) (a) The substance has a low potential for abuse relative to substances included in schedule III;
961.19(1m)(b) (b) The substance has currently accepted medical use in treatment in the United States; and
961.19(1m)(c) (c) Abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in schedule III.
961.19(2m) (2m)The controlled substances board may add a substance to schedule IV without making the findings required under sub. (1m) if the substance is controlled under schedule IV of 21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.19 History History: 1971 c. 219; 1995 a. 448 ss. 201, 202, 477; Stats. 1995 s. 961.19.
961.20 961.20 Schedule IV. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule IV:
961.20(2) (2) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.20(2)(a) (a) Alfaxalone;
961.20(2)(ak) (ak) Alprazolam;
961.20(2)(am) (am) Barbital;
961.20(2)(ap) (ap) Brexanolone;
961.20(2)(ar) (ar) Bromazepam;
961.20(2)(av) (av) Camazepam;
961.20(2)(ax) (ax) Carisoprodol;
961.20(2)(b) (b) Chloral betaine;
961.20(2)(c) (c) Chloral hydrate;
961.20(2)(cd) (cd) Clobazam;
961.20(2)(cg) (cg) Clotiazepam;
961.20(2)(cm) (cm) Chlordiazepoxide;
961.20(2)(cn) (cn) Clonazepam;
961.20(2)(co) (co) Cloxazolam;
961.20(2)(cp) (cp) Clorazepate;
961.20(2)(cq) (cq) Delorazepam;
961.20(2)(cr) (cr) Diazepam;
961.20(2)(cs) (cs) Dichloralphenazone;
961.20(2)(cu) (cu) Estazolam;
961.20(2)(d) (d) Ethchlorvynol;
961.20(2)(e) (e) Ethinamate;
961.20(2)(ed) (ed) Ethyl loflazepate;
961.20(2)(ef) (ef) Flualprazolam;
Effective date note NOTE: This paragraph was created eff. 10-27-20 by the creation of s. CSB 2.77, Wis. Adm. Code, by emergency rule EmR2037 under s. 961.11 (4m). EmR2037 expires 10-26-21 unless replaced sooner by the creation of s. CSB 2.77 by permanent rule.
961.20(2)(eg) (eg) Fludiazepam;
961.20(2)(ej) (ej) Flunitrazepam;
961.20(2)(em) (em) Flurazepam;
961.20(2)(en) (en) Fospropofol;
961.20(2)(eo) (eo) Halazepam;
961.20(2)(ep) (ep) Haloxazolam;
961.20(2)(eq) (eq) Ketazolam;
961.20(2)(eqm) (eqm) Lemborexant;
961.20(2)(er) (er) Lorazepam;
961.20(2)(es) (es) Loprazolam;
961.20(2)(eu) (eu) Lormetazepam;
961.20(2)(ew) (ew) Mebutamate;
961.20(2)(ey) (ey) Medazepam;
961.20(2)(f) (f) Methohexital;
961.20(2)(g) (g) Meprobamate;
961.20(2)(h) (h) Methylphenobarbital, which is also called mephobarbital;
961.20(2)(hg) (hg) Midazolam;
961.20(2)(hh) (hh) Nimetazepam;
961.20(2)(hj) (hj) Nitrazepam;
961.20(2)(hk) (hk) Nordiazepam;
961.20(2)(hm) (hm) Oxazepam;
961.20(2)(hr) (hr) Oxazolam;
961.20(2)(j) (j) Paraldehyde;
961.20(2)(k) (k) Petrichloral;
2019-20 Wisconsin Statutes updated through 2021 Wis. Act 54 and through all Supreme Court and Controlled Substances Board Orders filed before and in effect on July 1, 2021. Published and certified under s. 35.18. Changes effective after July 1, 2021, are designated by NOTES. (Published 7-1-21)